Editorial
doi: 10.1001/jama.293.23.2932.
Pharmacotherapy for adolescent obesity: a weighty issue
- PMID: 15956639
- DOI: 10.1001/jama.293.23.2932
Item in Clipboard
Editorial
Pharmacotherapy for adolescent obesity: a weighty issue
JAMA.
.
No abstract available
Comment on
-
Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.JAMA. 2005 Jun 15;293(23):2873-83. doi: 10.1001/jama.293.23.2873. JAMA. 2005. PMID: 15956632 Clinical Trial.
Similar articles
-
[Pharmacotherapy of obesity].Ugeskr Laeger. 2004 Oct 18;166(43):3814-7. Ugeskr Laeger. 2004. PMID: 15544112 Danish. No abstract available.
-
Rapidly progressive renal failure associated with successful pharmacotherapy for obesity.Nephrol Dial Transplant. 2007 Aug;22(8):2403-5; author reply 2405. doi: 10.1093/ndt/gfm203. Epub 2007 May 21. Nephrol Dial Transplant. 2007. PMID: 17517801 No abstract available.
-
[Pharmacotherapy for obesity].Ugeskr Laeger. 2016 Oct 31;178(44):V06160406. Ugeskr Laeger. 2016. PMID: 27808050 Review. Danish.
-
Early weight loss and outcome at one year in obese adolescents treated with orlistat or placebo.Int J Pediatr Obes. 2011 Apr;6(2):95-101. doi: 10.3109/17477166.2010.519387. Epub 2010 Sep 22. Int J Pediatr Obes. 2011. PMID: 20858149 Clinical Trial.
-
Pharmacotherapy for obesity: What you need to know.Cleve Clin J Med. 2017 Dec;84(12):951-958. doi: 10.3949/ccjm.84a.16094. Cleve Clin J Med. 2017. PMID: 29244650 Review.
Cited by
-
A review of adolescent obesity: prevalence, etiology, and treatment.Obes Surg. 2009 Jan;19(1):113-20. doi: 10.1007/s11695-008-9650-4. Epub 2008 Aug 30. Obes Surg. 2009. PMID: 18758874 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
